AGL 38.51 Increased By ▲ 0.03 (0.08%)
AIRLINK 199.70 Decreased By ▼ -3.32 (-1.64%)
BOP 9.95 Decreased By ▼ -0.22 (-2.16%)
CNERGY 6.35 Decreased By ▼ -0.19 (-2.91%)
DCL 9.39 Decreased By ▼ -0.19 (-1.98%)
DFML 39.45 Decreased By ▼ -0.57 (-1.42%)
DGKC 97.99 Decreased By ▼ -0.09 (-0.09%)
FCCL 35.27 Increased By ▲ 0.31 (0.89%)
FFBL 87.21 Increased By ▲ 0.78 (0.9%)
FFL 13.64 Decreased By ▼ -0.26 (-1.87%)
HUBC 128.70 Decreased By ▼ -2.87 (-2.18%)
HUMNL 13.87 Decreased By ▼ -0.15 (-1.07%)
KEL 5.30 Decreased By ▼ -0.31 (-5.53%)
KOSM 7.43 Increased By ▲ 0.16 (2.2%)
MLCF 45.25 Decreased By ▼ -0.34 (-0.75%)
NBP 61.30 Decreased By ▼ -5.08 (-7.65%)
OGDC 215.99 Decreased By ▼ -4.77 (-2.16%)
PAEL 39.49 Increased By ▲ 1.01 (2.62%)
PIBTL 8.52 Decreased By ▼ -0.39 (-4.38%)
PPL 194.30 Decreased By ▼ -3.58 (-1.81%)
PRL 39.12 Increased By ▲ 0.09 (0.23%)
PTC 25.55 Increased By ▲ 0.08 (0.31%)
SEARL 104.89 Increased By ▲ 1.84 (1.79%)
TELE 8.73 Decreased By ▼ -0.29 (-3.22%)
TOMCL 36.33 Decreased By ▼ -0.08 (-0.22%)
TPLP 13.87 Increased By ▲ 0.12 (0.87%)
TREET 24.61 Decreased By ▼ -0.51 (-2.03%)
TRG 57.55 Decreased By ▼ -0.49 (-0.84%)
UNITY 33.25 Decreased By ▼ -0.42 (-1.25%)
WTL 1.65 Decreased By ▼ -0.06 (-3.51%)
BR100 11,815 Decreased By -75.1 (-0.63%)
BR30 36,809 Decreased By -548 (-1.47%)
KSE100 109,848 Decreased By -1222.4 (-1.1%)
KSE30 34,510 Decreased By -399.3 (-1.14%)
World

Italy's Draghi dismisses China's COVID vaccine, casts doubt on Sputnik

  • "The Russian vaccine Sputnik has never been able to get approval from EMA and perhaps it never will," Draghi said.
Published June 25, 2021

BRUSSELS: Italian Prime Minister Mario Draghi said China's anti-COVID vaccine did not fully work and questioned whether Russia's Sputnik jab would ever get approval from European regulators.

"The Chinese vaccine ... has shown itself not to be adequate. You can see that from Chile's experience of tackling the epidemic," Draghi told reporters at the end of a European Union summit.

Chile has relied heavily on the COVID-19 shot developed by China's Sinovac, but health authorities in the South American country have questioned how effective it is against more transmissible virus variants and are also looking into how long it remains effective once injected.

A study published in April said the Chinese vaccine proved minimally effective at preventing illness after one dose. With a second jab, it was 67% effective in preventing symptomatic infection, 85% effective in preventing hospitalizations and 80% in preventing deaths.

Draghi also questioned Russia's Sputnik vaccine.

The European Medicines Agency (EMA) had been expected to conclude its review of the Russian jab and issue a decision in May or June. However, approval was delayed because the makers missed a June 10 deadline to submit data, sources told Reuters earlier this month.

"The Russian vaccine Sputnik has never been able to get approval from EMA and perhaps it never will," Draghi said.

Comments

Comments are closed.